Editor’s Note: Related tickers: Smith & Wesson Holding Corp (NASDAQ:SWHC), Mellanox Technologies, Ltd. (NASDAQ:MLNX), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), China Commercial Credit Inc (NASDAQ:CCCR)
Los Angeles County Sheriff’s Department Selects Smith & Wesson M&P Pistols (Ammoland)
Smith & Wesson Holding Corp (NASDAQ:SWHC), a leader in firearm manufacturing and design, today announced that it has been awarded a firearms contract from the Los Angeles County Sheriff?s Department (LASD) for new service firearms from the Company?s M&P Pistol Series. As part of a five-year contract, the LASD will purchase Smith & Wesson M&P9 pistols which will replace currently issued non-Smith & Wesson Holding Corp (NASDAQ:SWHC) firearms. The Los Angeles County Sheriff?s Department fields approximately 13,000 sworn and non-sworn personnel who are issued duty handguns.
Mellanox and Micron Announce 40 GigE Flash Storage for Virtualized Data Centers (ConvergeDigest)
Mellanox Technologies, Ltd. (NASDAQ:MLNX) and Micron today announced a collaborative solution that combines Mellanox’s ConnectX-3 40GbE NICs with iSCSI over RDMA (iSER) and Micron’s 1.4TB P420m PCIe SSD cards. The companies said the iSER protocol enables Micron’s flash storage to serve virtual machines on a single ESXi 5.1 host with an aggregate bandwidth of 11GB/s or 527,000 IOPS using only two interconnect cards in a 3U box. “The combined solution of Mellanox’s 40GbE NICs with iSER and Micron’s P420m PCIe SSD enables higher performance and accelerates storage applications running in virtualized environments,” said Yaron Haviv, vice president data center solutions at Mellanox Technologies, Ltd. (NASDAQ:MLNX).
Why Catalyst Pharmaceutical Partners is up 45 Percent Tuesday (CPRX) (BreakingFinanceNews)
Shares of Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) are up 45 percent in early trading Tuesday after the company announced that its investigational drug, Firdapse has received “Breakthrough Therapy Designation” by the U.S. Food and Drug Administration. Firdapse is indicated for the symptomatic treatment of patients with Lambert-Eaton Myasthenic Syndrome, a neuromuscular condition. Breakthrough Therapy Designation is granted to a drug this is, “intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates…
China Commercial Credit Issues Outlook for Coming Year; Projects ‘Improved Revenue and Profit Growth’ (BusinessReviewUSA)
China Commercial Credit Inc (NASDAQ:CCCR), a microcredit company providing loans and loan guarantees to small-to-medium sized enterprises (SMEs), farmers and individuals, today issued a corporate outlook for the next 12 months. Mr. Huichun Qin, founder and CEO, cited three primary factors expected to fuel the company’s growth: …CCC’s improved access to capital. As a result of raising $8.9 million in its recent IPO — thereby becoming the first China-based microcredit company to go public in the U.S.
Stocks Buzz: Smith & Wesson Holding Corp (NASDAQ:SWHC), First Niagara Financial Group Inc. (NASDAQ:FNFG, TiVo Inc. (NASDAQ:TIVO), PMC-Sierra Inc (TechSonian)
VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. …Smith & Wesson Holding Corp (NASDAQ:SWHC) opened the session at $11.21, remained amid the day range of $10.99 – $11.30, and closed the session at $11.02. The stock showed a negative performance of -1.69% in previous trading session. The stock gained a volume of 1.90 million shares and the average volume of the stock remained 2.36 million shares. Will SWHC Get Buyers Even After The Recent Rally?
Should You Avoid Mellanox Technologies, Ltd. (MLNX)? (InsiderMonkey)
In today’s marketplace, there are a multitude of metrics investors can use to monitor stocks. A duo of the most useful are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best investment managers can beat the market by a significant amount (see just how much). …Due to the fact Mellanox Technologies, Ltd. (NASDAQ:MLNX) has faced declining interest from upper-tier hedge fund managers, it’s safe to say that there exists a select few funds who sold off their entire stakes at the end of the second quarter.
Catalyst Pharmaceutical Partners Receives Breakthrough Therapy Designation From FDA for Firdapse(TM) for the Treatment of LEMS (Nasdaq)
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, today announced that its investigational product Firdapse™ (amifampridine phosphate) has received “Breakthrough Therapy Designation” by the U.S. Food and Drug Administration (FDA) for the symptomatic treatment of patients with Lambert-Eaton Myasthenic Syndrome (LEMS). Firdapse™ is Catalyst’s investigational therapy that is being evaluated for the treatment of the debilitating symptoms associated with LEMS, including muscle weakness.
China commercial credit IPO (ECNS)
A small Chinese financial company is creating a stir among some U.S. investors. China Commercial Credit Inc (NASDAQ:CCCR), whose subsidiary underwrites microloans to small companies in China’s Jiangsu province, emerged from its first week of trading on Nasdaq, up 40 percent to around nine dollars per share. Is this a sign of renewed U.S. interest in Chinese stocks, and what does it mean for China’s shadow banking system? For China Commercial Credit Inc (NASDAQ:CCCR), this was a volatile first week that ended on a high note. Its U.S. reception when it launched August 14th was lukewarm-with the IPO raising only $8.9 million dollars.
